Cargando…
Identification of tumor antigens and immune subtypes of acute myeloid leukemia for mRNA vaccine development
BACKGROUND: Acute myeloid leukemia (AML) is a highly aggressive hematological malignancy, and there has not been any significant improvement in therapy of AML over the past several decades. The mRNA vaccines have become a promising strategy against multiple cancers, however, its application on AML r...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924891/ https://www.ncbi.nlm.nih.gov/pubmed/36781600 http://dx.doi.org/10.1007/s12094-023-03108-6 |